Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
for Advanced Melanoma
11 locations incl. Chandler
Sponsor: Eikon Therapeutics
Sex: All·Age: 18+
Code: NCT06697301·Phase 2, Phase 3·Recruiting·Listed Nov 2024